This revealed that a SETD2 deleterious mutation was associated with a more inflamed tumor microenvironment in patients with renal cell carcinoma (Figure S4A), colorectal adenocarcinoma (Figure S4B), and endometrial carcinoma (Figure S4C). The gene discussed is SETD2; the disease is hereditary clear cell renal cell carcinoma.